Skip to main content
Erschienen in: Journal of Bioethical Inquiry 1/2018

01.03.2018 | Critical Perspectives

Mode 2 Knowledge Production in the Context of Medical Research: A Call for Further Clarifications

verfasst von: Hojjat Soofi

Erschienen in: Journal of Bioethical Inquiry | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

The traditional researcher-driven environment of medical knowledge production is losing its dominance with the expansion of, for instance, community-based participatory or participant-led medical research. Over the past few decades, sociologists of science have debated a shift in the production of knowledge from traditional discipline-based (Mode 1) to more socially embedded and transdisciplinary frameworks (Mode 2). Recently, scholars have tried to show the relevance of Mode 2 knowledge production to medical research. However, the existing literature lacks detailed clarifications on how a model of Mode 2 knowledge production can be constructed in the context of medical research. This paper calls for such further clarifications. As a heuristic means, the advocacy for a controversial experimental stem cell therapy (Stamina) is examined. It is discussed that the example cannot be considered a step towards Mode 2 medical knowledge production. Nonetheless, the example brings to the fore some complexities of medical knowledge production that need to be further examined including: (1) the shifting landscape of defining and addressing vulnerability of research participants, (2) the emerging overlap between research and practice, and (3) public health implications of revising the standard notions of quality control and accountability.
Literatur
Zurück zum Zitat Blasimme, A., and E. Rial-Sebbag. 2013. Regulation of cell-based therapies in Europe: Current challenges and emerging issues. Stem Cells and Development 22(S1): 14–19. Blasimme, A., and E. Rial-Sebbag. 2013. Regulation of cell-based therapies in Europe: Current challenges and emerging issues. Stem Cells and Development 22(S1): 14–19.
Zurück zum Zitat Crompton, H. 2007. Mode 2 knowledge production: Evidence from orphan drug networks. Science and Public Policy 34(3): 199–211. Crompton, H. 2007. Mode 2 knowledge production: Evidence from orphan drug networks. Science and Public Policy 34(3): 199–211.
Zurück zum Zitat Frati, P., G. Frati, M. Gulino, G. M. Vergallo, A. Di Luca, and V. Fineschi. 2013. Stem cell therapy: From evidence-based medicine to emotion-based medicine? The long Italian way for a scientific regulation. Stem Cell Research & Therapy 4:122. Frati, P., G. Frati, M. Gulino, G. M. Vergallo, A. Di Luca, and V. Fineschi. 2013. Stem cell therapy: From evidence-based medicine to emotion-based medicine? The long Italian way for a scientific regulation. Stem Cell Research & Therapy 4:122.
Zurück zum Zitat Gibbons, M., C. Limoges, H. Nowotny, S. Schwartzman, P. Scott and M. Trow, 1994. The new production of knowledge. The dynamics of science and research in contemporary societies. London, Sage. Gibbons, M., C. Limoges, H. Nowotny, S. Schwartzman, P. Scott and M. Trow, 1994. The new production of knowledge. The dynamics of science and research in contemporary societies. London, Sage.
Zurück zum Zitat Kipnis, K. 2001. Vulnerability in research subjects: A bioethical taxonomy. Ethical and policy issues in research involving human participants 2: G1–13. Bethesda. National Bioethics Advisory Commission. Kipnis, K. 2001. Vulnerability in research subjects: A bioethical taxonomy. Ethical and policy issues in research involving human participants 2: G1–13. Bethesda. National Bioethics Advisory Commission.
Zurück zum Zitat Largent, E.A., S. Joffe, and F.G. Miller. 2011. Can research and care be ethically integrated? Hastings Center Report 41: 37–46. Largent, E.A., S. Joffe, and F.G. Miller. 2011. Can research and care be ethically integrated? Hastings Center Report 41: 37–46.
Zurück zum Zitat Lowes, L.P., G.H. Noritz, A. Newmeyer, P.J. Embi, H. Yin, and W.E. Smoyer. 2016. ‘Learn from every patient’: Implementation and early results of a learning health system. Developmental Medicine & Child Neurology 59(2): 183–191. Lowes, L.P., G.H. Noritz, A. Newmeyer, P.J. Embi, H. Yin, and W.E. Smoyer. 2016. ‘Learn from every patient’: Implementation and early results of a learning health system. Developmental Medicine & Child Neurology 59(2): 183–191.
Zurück zum Zitat Margottini, L. 2013. Italian parliament orders €3 million trial of disputed therapy. Science 340(6136): 1028. Margottini, L. 2013. Italian parliament orders €3 million trial of disputed therapy. Science 340(6136): 1028.
Zurück zum Zitat Nowotny, H., P. Scott, and M. Gibbons. 2001. Re-thinking science: Knowledge and the public in an age of uncertainty. Cambridge: Polity Press. Nowotny, H., P. Scott, and M. Gibbons. 2001. Re-thinking science: Knowledge and the public in an age of uncertainty. Cambridge: Polity Press.
Zurück zum Zitat ----. 2003. ‘Mode 2’ revisited: The new production of knowledge. Minerva 41: 179–194. ----. 2003. ‘Mode 2’ revisited: The new production of knowledge. Minerva 41: 179–194.
Zurück zum Zitat ----. 2006. Re-thinking science: Mode 2 in societal context. In Knowledge creation, diffusion, and use in innovation networks and knowledge clusters. A comparative systems approach across the United States, Europe and Asia, edited by E.G. Carayannis and D.F. Campbell, 39–51. Westport: Greenwood Publishing Group. ----. 2006. Re-thinking science: Mode 2 in societal context. In Knowledge creation, diffusion, and use in innovation networks and knowledge clusters. A comparative systems approach across the United States, Europe and Asia, edited by E.G. Carayannis and D.F. Campbell, 39–51. Westport: Greenwood Publishing Group.
Zurück zum Zitat Özdemir, V., E. Fisher, E.S. Dove, et al. 2012. End of the beginning and public health pharmacogenomics: Knowledge in ‘Mode 2’ and P5 Medicine. Current Pharmacogenomics and Personalized Medicine 10(1): 1–6. Özdemir, V., E. Fisher, E.S. Dove, et al. 2012. End of the beginning and public health pharmacogenomics: Knowledge in ‘Mode 2’ and P5 Medicine. Current Pharmacogenomics and Personalized Medicine 10(1): 1–6.
Zurück zum Zitat Rial-Sebbag, E., and A. Blasimme. 2014. The European Court of Human Rights’ ruling on unproven stem cell therapies: A missed opportunity? Stem Cells and Development 23(S1): 39–43. Rial-Sebbag, E., and A. Blasimme. 2014. The European Court of Human Rights’ ruling on unproven stem cell therapies: A missed opportunity? Stem Cells and Development 23(S1): 39–43.
Zurück zum Zitat Smikowski, J., S. Dewane, M.E. Johnson, C. Brems, C. Bruss and L.W. Roberts. 2009. Community-based participatory research for improved mental health. Ethics and Behavior 19(6): 461–478. Smikowski, J., S. Dewane, M.E. Johnson, C. Brems, C. Bruss and L.W. Roberts. 2009. Community-based participatory research for improved mental health. Ethics and Behavior 19(6): 461–478.
Zurück zum Zitat Wallerstein, N., and B. Duran. 2010. Community-based participatory research contributions to intervention research: The intersection of science and practice to improve health equity. American Journal of Public Health 100( S1): S40–S46. Wallerstein, N., and B. Duran. 2010. Community-based participatory research contributions to intervention research: The intersection of science and practice to improve health equity. American Journal of Public Health 100( S1): S40–S46.
Zurück zum Zitat Welch, M.J., R. Lally, J.E. Miller, et al. 2015. The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials. Clinical Trials 12(5): 503–510. Welch, M.J., R. Lally, J.E. Miller, et al. 2015. The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials. Clinical Trials 12(5): 503–510.
Metadaten
Titel
Mode 2 Knowledge Production in the Context of Medical Research: A Call for Further Clarifications
verfasst von
Hojjat Soofi
Publikationsdatum
01.03.2018
Verlag
Springer Singapore
Erschienen in
Journal of Bioethical Inquiry / Ausgabe 1/2018
Print ISSN: 1176-7529
Elektronische ISSN: 1872-4353
DOI
https://doi.org/10.1007/s11673-017-9822-9

Weitere Artikel der Ausgabe 1/2018

Journal of Bioethical Inquiry 1/2018 Zur Ausgabe